Predicting type 1 diabetes

被引：35

作者：

Achenbach P. ^{[1
]}

Bonifacio E. ^{[1
]}

Ziegler A.-G. ^{[1
]}

机构：

[1] Diabetes Research Institute, Munich 80804, Koelner Platz I

来源：

Current Diabetes Reports | 2005年 / 5卷 / 2期

关键词：

Islet Autoantibody; Islet Autoimmunity; Diabetes Prevention Trial; Multiple Islet Autoantibody; Diabetes Antibody Standardization Program;

D O I：

10.1007/s11892-005-0035-y

中图分类号：

学科分类号：

摘要：

Predicting type 1 diabetes mellitus (T1DM) is a prerequisite for disease prevention. Prediction is currently performed on three levels, which include the genetic susceptibility for disease, the identification of preclinical T1DM by way of circulating islet autoantibodies, and the use of metabolic tests to stage preclinical disease into late or early prediabetes. Combinations of genetic markers such as HLA genotype, INS genotype, and if and how much family history of T1DM is present can stratify disease risk more than 1000-fold, and can be used for selection of first-degree relatives of patients with T1DM for primary intervention trials. Measurement of autoantibodies in genetically at-risk subjects identifies future cases of T1DM. Further stratification of diabetes risk in autoantibody-positive subjects can be made on the basis of autoantibody characteristics that correspond to the magnitude of the autoantibody response. Copyright © 2005 by Current Science Inc.

引用

页码：98 / 103

页数：5

共 50 条

[11]

Yu J., Yu L., Bugawan T.L., Et al., Transient anti-islet autoantibodies: Infrequent occurrence and lack of association with "genetic" risk factors, J. Clin. Endocrinol. Metab., 85, pp. 2421-2428, (2000)

[12]

Laine A.P., Hermann R., Knip M., Et al., The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population, Tissue Antigens, 63, pp. 72-74, (2004)

[13]

Motzo C., Contu D., Cordell H.J., Et al., Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes, Diabetes, 53, pp. 3286-3291, (2004)

[14]

Ziegler A.G., Schmid S., Huber D., Et al., Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies, JAMA, 290, pp. 1721-1728, (2003)

[15]

Norris J.M., Barriga K., Klingensmith G., Et al., Timing of initial cereal exposure in infancy and risk of islet autoimmunity, JAMA, 290, pp. 1713-1720, (2003)

[16]

Yu L., Cuthbertson D.D., Eisenbarth G.S., Krischer J.P., Diabetes Prevention Trial 1: Prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband, Ann. N. Y. Acad. Sci., 958, pp. 254-258, (2002)

[17]

Bonifacio E., Hummel M., Walter M., Et al., IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes, Diabetes Care, 27, pp. 2695-2700, (2004)

[18]

Atkinson M.A., Eisenbarth G.S., Type 1 diabetes: New perspectives on disease pathogenesis and treatment, Lancet, 358, pp. 221-229, (2001)

[19]

Bingley P.J., Bonifacio E., Ziegler A.G., Et al., Proposed guidelines on screening for risk of type 1 diabetes, Diabetes Care, 24, (2001)

[20]

Bingley P.J., Bonifacio E., Mueller P.W., Diabetes antibody standardization program: First assay proficiency evaluation, Diabetes, 52, pp. 1128-1136, (2003)

← 1 2 3 4 5 →